Agenda | Abstracts | Speakers | What is Public Health? | Research | Conclusions

Howard Abikoff, Ph.D.
NYU Medical Center
550 First Avenue
New York, NY 10016

Dr. Abikoff is Professor of Clinical Psychiatry at New York University Medical Center and Director of Research at the NYU Child Study Center. Dr. Abikoff’s clinical research activities have spanned three interrelated areas: the development of novel treatment approaches, treatment evaluation and the development of measures to quantify treatment outcome. Much of his work has been funded by the National Institute of Mental Health, and has centered on treatment development and treatment evaluation of children with Attention Deficit Hyperactivity Disorder, as well as on youngsters with Conduct Disorder. These large clinical trials have compared the efficacy of pharmacological and psychosocial treatments, alone and in combination. More recently, as funded investigator of one of the NIMH supported Research Units in Pediatric Psychopharmacology (RUPP), Dr. Abikoff’s focused his research on the clinical efficacy of psychopharmacological compounds for youth with anxiety disorders. Dr. Abikoff has served as a reviewer on numerous NIMH panels and study sections, and recently participated as a member of the National Advisory Mental Health Council Clinical and Services Research Workgroup. He currently serves on the editorial boards of four peer reviewed journals, and has participated as an ad hoc reviewer on more than a dozen other psychology, psychiatry and educational journals.

Return to Top

Ann J. Abramowitz, Ph.D.

Dr. Abramowitz is a graduate of the University of Rochester in Psychology. In California, she taught children with autism for three years. She obtained a Masters degree in Learning Disabilities and Behavior Disorders from the University of Oregon, and taught special education students in California before moving to Williamsburg, VA. There, she coordinated the school district's noncategorical preschool handicapped program and early identification efforts. She then was Coordinator of Special Education. She obtained her Ph.D. in Clinical Psychology from the State University of New York at Stony Brook in 1988, serving her clinical internship at the Emory University School of Medicine. Currently, she is Associate Professor of Psychiatry and Behavioral Sciences at Emory University School of Medicine, where she is Director of the Center for Learning and Attention Deficit Disorders. In this capacity, she and her staff evaluate children and adolescents with learning, behavioral, and/or attentional problems, and provide treatment that includes behavioral family therapy, individual behavior therapy, and school consultations. She is a co-investigator on the NIMH multi-site study of multimodal treatment of ADHD (Columbia/Mt. Sinai site), and collaborates on research investigating the genetic bases of ADHD.

She consults with the Centers for Disease Control and Prevention on the current project involving public health issues and ADHD.

Return to Top

Thomas M. Achenbach, Ph.D.
Department of Psychiatry
University of Vermont
1 South Prospect Street
Burlington, VT 05401-3456

Thomas M. Achenbach, Professor of Psychiatry and Psychology, is Director of the Center for Children, Youth, and Families at the University of Vermont Department of Psychiatry. A summa cum laude graduate of Yale, he received his Ph.D. from the University of Minnesota and was a Post-doctoral Fellow at the Yale Child Study Center. Before moving to the University of Vermont, Dr. Achenbach taught at Yale and was a Research Psychologist at the National Institute of Mental Health. He has been a DAAD Fellow at the University of Heidelberg, Germany; an SSRC Senior Faculty Fellow at Jean Piaget’s Centre d’Epistemologie Genetique in Geneva; Chair of the American Psychological Association’s Task Force on Classification of Children’s Behavior; and a member of the American Psychiatric Association’s Advisory Committee on DSM-III-R. He has authored over 150 publications, including Developmental Psychopathology; Research in Developmental Psychology: Concepts, Strategies, Methods; Assessment and Taxonomy of Child and Adolescent Psychopathology; Empirically Based Taxonomy; Empirically Based Assessment of Child and Adolescent Psychopathology (with Stephanie H. McConaughy); and Manuals for the Child Behavior Checklist, Teacher’s Report Form, Youth Self-Report, and other standardized assessment instruments. Dr. Achenbach’s honors include the Distinguished Contribution Award of the American Psychological Association’s Section on Clinical Child Psychology and the University Scholar Award of the University of Vermont.

Return to Top

Louis C. Danielson, Ph.D.
Department of Education
Office of Special Education, Room 3553
Switzer Building
331 C Street, SW
Washington, DC 20202

Louis Danielson, a national leader in the field of special education, has been involved in programs that improve results for students with disabilities for nearly three decades. He brings an unparalleled depth of knowledge in both special education policy and research to his current position as Director of the Research to Practice Division in the Office of Special Education Programs (OSEP) at the U.S. Department of Education. Dr. Danielson was awarded a Ph.D. in educational psychology from Pennsylvania State University in 1976. During his career, he has served many roles in the field of education, including secondary school science and mathematics teacher, school psychologist, and teacher at the university level. For the past twenty-three years, Dr. Danielson has held leadership roles in OSEP and is currently responsible for the discretionary grants program, including research, technical assistance and dissemination, personnel preparation, technology, and parent training priorities, national evaluation activities, and other major policy-related studies in OSEP. He has served in numerous research and policy roles across the Department and has represented OSEP in major school reform activities. A frequent contributor to professional journals, Dr. Danielson has published extensively in the literature and is a frequent speaker at national and international conferences and events focusing on special education. His particular areas of interest include policy implementation and national evaluation studies.

Return to Top

Laurence L. Greenhill, M.D.
New York State Psychiatric Institute
1051 Riverside Drive, Room 2302
New York City, NY 10032

Dr. Greenhill is a professor of Clinical Psychiatry at Columbia University and Medical Director of the Disruptive Behavior Disorders Clinic at Columbia Presbyterian Medical Center. Dr. Greenhill is a internationally recognized expert in psychopharmacology and, in particular, such treatments for ADHD. He has conducted research on efficacy of sustained release methylphenidate preparations, familial pathways in offspring of adult suicide attempters, effects of age on the cardiovascular responses to tricyclic antidepressants, and the efficacy of multimodal treatments in children with ADHD. He is the principal investigator of three NIMH grants, including the New York State Psychiatric Institute site of the Multimodal Treatment Study of Attention Deficit Hyperactivity Disorder (MTA Study). He currently holds several pharmaceutical company contracts to investigate efficacy and safety of a variety of psychopharmacological interventions. Dr. Greenhill is the author of over 50 published articles and has edited three books, including a monograph on methylphenidate. He serves as the current Chair of the Steering Committee of the MTA Study and coordinated the development of its medication manual. He has completed a five-year term as a member of the Workgroup on Research of the Academy of Child and Adolescent Psychiatry, sits on the Scientific Advisory Board to the University of Pittsburgh Adolescent Alcoholism Research Center, and is a member of the NIMH Data Safety and Monitoring Board.

Return to Top

Jeffrey M. Halperin, Ph.D.
Department of Psychology
Queens College
65-30 Kissena Boulevard
Flushing, NY 11367

Dr. Halperin is a Professor of Psychology at Queens College and the Graduate School and University Center of the City University of New York (CUNY), and Head of the Neuropsychology Doctoral Subprogram of CUNY. In addition, he is a Professorial Lecturer in the Department of Psychiatry at the Mount Sinai School of Medicine. Dr. Halperin received his Ph.D. in Psychology from CUNY in 1979, and completed a Post-doctoral Fellowship in Psychopharmacology at Schering - Plough Pharmaceutical Corporation in 1980. For nearly two decades Dr. Halperin has been conducting research on diagnostic and treatment issues, as well as neural functioning, in children with ADHD. A primary focus of his research has been to develop objective measures to evaluate symptomatology in children with ADHD and to use these measures to identify more homogeneous subgroups of children with the disorder. In addition, through the use of neuropsychological and neurochemical measures, he has examined the ways in which neural substrates might differ in subgroups of children with ADHD as a function of comorbidity and learning disabilities.

Return to Top

Stephen P. Hinshaw, Ph.D.
Department of Psychology #1650
University of California at Berkeley
3210 Tolman Hall
Berkeley, CA 94720-1650

Stephen Hinshaw is Professor of Psychology and Director of Clinical Psychology Training at the University of California, Berkeley. He received his A.B. from Harvard in 1974, and he subsequently directed day school and residential programs for children with developmental disabilities in New England. He received his Ph.D. in Clinical Psychology from UCLA in 1983. He was a clinical psychology intern at UCLA's Neuropsychiatric Institute from 1981-2 and a post-doctoral fellow at the Langley Porter Psychiatric Institute of the University of California, San Francisco, from 1983-5. He taught in the Psychology Department at UCLA from 1986-1990 and joined the Berkeley faculty in 1990. His work focuses on developmental psychopathology, with particular emphasis on (a) peer and family relationships in children with externalizing disorders, (b) neuropsychological risk factors for and correlates of psychopathology, (c) comparisons and combinations of pharmacologic and psychological interventions for children with ADHD, (d) assessment and evaluation, and (e) conceptual and definitional issues in the field. He has authored over 90 articles and chapters on child psychopathology; his book, Attention Deficits and Hyperactivity in Children, was published by Sage Publications in 1994. He is on the editorial board of several leading journals in the field and is currently President of the International Society for Research in Child and Adolescent Psychopathology.

Return to Top

Kimberly Hoagwood, Ph.D.

Dr. Hoagwood is Associate Director of Child and Adolescent Mental Health Research at the National Institute of Mental Health. She also holds the positions of Chief of Child Mental Health Services Research and Chief of Treatment and Service Effectiveness Research. Prior to her appointment at NIMH, Dr. Hoagwood was Research Director at the Texas Education Agency, where she supervised a state-wide, cross-agency program of evaluation on school-based services for children with serious mental disorders. Dr. Hoagwood earned her doctorate in School Psychology, and practiced clinically for nine years. She has held academic appointments at the Pennsylvania State University and the University of Maryland. Among her numerous publications are articles examining clinical and service effectiveness in children’s services, trends in psychotropic medication practices, treatment services for ADHD, and genetic epistemology in the work of Gabriel Garcia-Márquez.

Return to Top

Peter S. Jensen, M.D.
Center for the Implementation of Science in Child Mental Health
Division of Child and Adolescent Psychiatry
New York State Psychiatric Institute
Columbia University
New York, NY 10032

Dr. Jensen is the Associate Director of Child and Adolescent Research at the National Institute of Mental Health (NIMH), currently on special assignment to the Division of Child & Adolescent Psychiatry, Columbia University. Formerly with the Walter Reed Army Institute of Research, Dr. Jensen joined NIMH in 1989. Dr. Jensen is the lead NIMH investigator on the six-site NIMH and Department of Education-funded study of Multimodal Treatment of ADHD (the MTA Study), and is also an investigator on other NIMH multi-site studies. Dr. Jensen serves on a number of editorial and scientific advisory boards (including the CH.A.D.D. Professional Advisory Board and the Tourettes Syndrome Association Scientific Board), is the author of over 100 scientific articles and chapters, and has edited two books on children's mental health research. For his research, writing, and teaching, he has received many national awards, including the Norbert Reiger Award from the American Academy of Child and Adolescent Psychiatry (twice, 1990 and 1996), the Agnes Purcell McGavin Award (1996) and the Blanche Ittelson Award (1998) from the American Psychiatric Association, Special Recognition Awards from the American Psychological Association and the Association for Child Psychiatric Nursing, and most recently, the Exemplary Psychiatrist Award from the National Alliance for the Mentally Ill. He and Susi Myers Jensen (from Palo Alto) have 5 children, aged 14 to 23.

Return to Top

Rachel G. Klein, Ph.D.
New York State Psychiatric Institute
Unit #80
722 West 168th Street
New York, NY 10032

Dr. Rachel Klein is Professor of Clinical Psychology (in Psychiatry) at Columbia University, College of Physicians and Surgeons, and Director of Clinical Psychology, New York State Psychiatric Institute and Columbia Presbyterian Medical Center. She has been an active investigator of childhood psychopathology for over three decades. She has been the recipient of numerous grant awards from the NIMH to investigate the treatment, as well as the natural history, of childhood and adolescent psychopathology. She has conducted major controlled treatment studies of the clinical efficacy of psychotherapeutic, as well as psychopharmacologic, interventions in children and adolescents. Her therapeutics research has spanned a broad spectrum of psychopathology, attention deficit hyperactivity disorder, conduct disorder, learning disorders, anxiety disorders, and major depression. Her interest in developmental psychopathology has led to longitudinal studies of children and adolescents with separation anxiety disorder, with attention deficit hyperactivity disorder, and with learning disorders. Her more recent related activities focus on risk factors for the development of psychiatric disorders in young children. Dr. Klein has published numerous scientific papers in child psychopathology. She has played a major role in the mentoring of junior researchers who have gone on to become well-known independent investigators.

Return to Top

Gretchen B. LeFever, Ph.D.
Center for Pediatric Research, CHKD/EVMS
855 West Brambleton Avenue
Norfolk, VA 23510-1001

Dr. LeFever is a practicing clinical psychologist and Founding Director of the School Health Initiative for Education (SHINE), a coalition in eastern Virginia comprised of school districts, health care providers, and others dedicated to improving the mental health and physical health of school children. She is also an Assistant Professor of Pediatrics at the Eastern Virginia Medical School in the Center for Pediatric Research. Dr. LeFever has presented and published a number of papers on the epidemiology, diagnosis, and management of attention deficit hyperactivity disorder (ADHD), and is a nationally recognized expert in child behavioral and developmental disorders.

Return to Top

Christopher P. Lucas, M.D.
New York State Psychiatric Institute
Unit #78
722 West 168th Street
New York, NY 10032

Dr. Lucas obtained his medical and psychiatric training at the University of Leeds, UK. Whilst in England he computerized an Audio CASI version of the NIMH DISC 2.1 using interactive-video / laser-disc technology. He joined the department of Child Psychiatry at Columbia University in 1993 as an NIMH Research Fellow and worked with Dr. David Shaffer on a suicide-screening project in a high school population. He obtained a Scientist Development Award for Clinicians from NIMH (K-20) in 1995 to study the measurement of child psychopathology. This grant comprises a series of projects studying the development of a general purpose diagnostic screening instrument (The DISC Predictive Scales – DPS), the computerization of a self-completion (Audio CASI) version of the NIMH Diagnostic Interview Schedule for Children – The Voice DISC computer, together with other experimental studies of the reliability and validity of diagnostic assessments. For the past five years, he has directed a team of programmers and research assistants devising and testing computerized versions of the NIMH-DISC. More recently the Columbia DISC Development Group (of which he is the Research Director) has been developing a general purpose authoring system (JADE) which will allow non-programmers to computerize complex interview batteries (incorporating audio-CASI and multilingual capabilities). Dr. Lucas’ current research interests include testing the DSM-IV version of the DISC Predictive Scales (DPS-4) in a large representative population-based sample, experimental studies of the reliability and validity of Audio-CASI versions of the DPS-4 and DISC, as well as adapting the DISC for use by the parents of pre-school children (the Young Child DISC).

Return to Top

William E. Pelham, Jr., Ph.D.
Department of Psychology
Park Hall
SUNY Buffalo
Buffalo, NY 14260

Dr. Pelham is a graduate of Dartmouth College and earned his Ph.D. in Clinical Psychology from the State University of New York at Stony Brook in 1976. He was been a faculty member in psychology department clinical training programs (Washington State University, Florida State University) from 1976 until 1986. From 1986 until 1996, he was the Director of the ADHD Clinic and Research Program and Professor of Psychiatry at Western Psychiatric Institute and Clinic, the University of Pittsburgh School of Medicine (WPIC), and he maintains a laboratory at WPIC as an adjunct Professor of Psychiatry. He is currently Professor of Psychology, Director of the ADHD Program, and Director of Clinical Training at the State University of New York at Buffalo. His summer treatment program for ADHD children has been recognized by the American Psychological Association (APA) as a Model Service Delivery program in Child and Family Mental Health (Roberts, 1996) and is widely recognized as the state of the art in treatment for ADHD. Dr. Pelham has authored or co-authored more than 125 professional papers and given more than 250 presentations dealing with ADHD and its treatment, both psychosocial and pharmacological. Dr. Pelham is a fellow of the American Psychological Association and the American Psychological Society, President of the Section on Child Clinical Psychology of Div. 12 of the APA, Past President of the International Society for Research in Child and Adolescent Psychopathology, and Past-President of the Professional Group for Attention Deficit and Related Disorders. He has held more than 20 research grants from federal agencies, foundations, and pharmaceutical companies, and is currently a Principal Investigator on multiple federal and industrial grants. He has served as a consultant/advisor on ADHD and related topics to several federal agencies, including NIMH, NIAAA, NIDA, IOM, OMAR, and the CDC.

Return to Top

Andrew S. Rowland, Ph.D.
NIEHS
P.O. Box 12233
Research Triangle Park, NC 27709-2233

Dr. Rowland received his undergraduate degree in "Health and Society" from the University of Pennsylvania, a Master’s degree in sociology from the University of California, Santa Cruz and a Doctoral degree in Epidemiology from the University of North Carolina, Chapel Hill. Dr. Rowland was trained as a reproductive and environmental epidemiologist and his dissertation was about the effects of occupational nitrous oxide exposure on the fertility of female dental assistants. In 1990, Dr. Rowland received the Greenberg dissertation award for the best dissertation at the UNC School of Public Health, as well as the Abraham Lililienfeld award from the Society for Epidemiologic Research for the best student paper based on a dissertation. Since that time, Dr. Rowland has been working as an epidemiologist at the National Institute of Environmental Health Sciences where his work has focused on the reproductive effects of heavy metals and pesticides. He became interested in the possible effects of environmental exposures during pregnancy on childhood development, which lead to his current research on ADHD. He is prinicipal investigator of a study of the prevalence of and risk factors for ADHD in a North Carolina County. Dr. Rowland is also an active member of the steering committee of a coalition of professionals and social service agencies who are working together to provide extra services to the children identified with ADHD by the epidemiologic study.

Return to Top

Russell Schachar, M.D.
Psychiatry Research
The Hospital for Sick Children
555 University Avenue
Toronto, Ontario M5G 1X8 Canada

Dr. Schachar was trained in medicine at the University of Toronto (graduated 1971) and completed his Fellowship in Psychiatry in the Department of Psychiatry at McMaster University (graduated 1975). Fellowship funding from the Ontario Mental Health Foundation and the Medical Research Council of Canada supported further training in research into child psychiatric disorders at the Institute of Psychiatry, University of London, London, England, under the supervision of Professor Sir Michael Rutter. Dr. Schachar's fellowship research involved studies of the epidemiology of Attention Deficit Hyperactivity Disorder (ADHD), effects of methylphenidate in ADHD, and the reliability of commonly used behaviour rating scales. Following this training, Dr. Schachar assumed a position in the Department of Psychiatry, the Hospital for Sick Children. After a period of five years, during which Dr. Schachar was director of the Outpatient Department of Psychiatry, he became the Director of Child Psychiatry Research within the Hospital and the Research Institute, as well as of the Division of Child Psychiatry within the Department of Psychiatry at the University of Toronto.

Currently, he is a Professor in the Faculty of Medicine, a Member of the Institute of Medical Science and a member of the post graduate faculty, Faculty of Education, University of Toronto. Dr. Schachar has been a Senior Research Fellow of the Ontario Mental Health Foundation and was the recipient in 1995 of the Elaine Schlosser Lewis Award from the American Academy of Child & Adolescent Psychiatry for his research on ADHD. Current research interests include cognition and psychopathology, genetics of ADHD, and treatment studies of disruptive behavior disorders.

Return to Top

David Shaffer F.R.C.P., F.R.C.Psych.
New York State Psychiatric Institute
723 West 168th Street
New York, NY 10032

Dr. Shaffer is an Irving Philips Professor of Child Psychiatry at the College of Physicians & Surgeons at Columbia University in New York City, and Chief of the Division of Child Psychiatry at Columbia Presbyterrian Medical Center and New York State Psychiatric Institute.  His principal research interests are in the measurement and classification of child psychiatric disorders and in the epidemiology and prevention of adolescent suicide. He co-chaired the DSM IV Child & Adolescent disorders work group and currently leads the child work group of the APA’s Committee on Diagnosis and Asessment. He is President of the American Foundation for Suicide Prevention and Past-President of the Society for Research in Child & Adolescent Psychopathology.

Dr. Shaffer has undertaken epidemiological studies on suicide and has assisted in the development of instruments for epidemiological purposes. His early research was on the relationship between Attention Deficit Hyperactivity Disorder and neurological disorder. He has written a number of papers on problems raised by the non-specificity of inattention and hyperactivity and on the difficulties in establishing a retrospective diagnosis of ADHD in adults. He received the American Suicide Foundation’s award for research in suicide in 1989, the American Mental Health Fund Research Award in 1990, and the American Psychiatric Association's McGavin Award in 1995. He was chosen to be a founding member of the Academy of Medical Sciences in London in1998.

Return to Top

Thomas J. Spencer, M.D.
Massachusetts General Hospital
Child Psychiatry WACC 625
Boston, MA 02114

Dr. Spencer is an Associate Professor of Psychiatry at Harvard Medical School and the Assistant Chief of the Pediatric Psychopharmacology Research Program at Massachusetts General Hospital. His research and clinical interests have focused on the effectiveness and safety of standard and novel pharmacologic treatments of Attention-Deficit/Hyperactivity Disorder (ADHD) throughout the lifecycle. In addition, Dr. Spencer’s research has focused on the characterization and treatment of Tic Disorders. He has received research funding from the Tourette Society and the National Institute of Mental Health (NIMH), and has published over 70 scientific articles and written 30 book chapters.

Before joining Massachusetts General Hospital, Dr. Spencer was the Head of the Clinical Team, Child and Adolescent Division, of the Massachusetts Department of Mental Health. He became a co-investigator in Dr. Biederman’s longitudinal and family-genetic studies of ADHD.

Dr. Spencer recently received an NIMH FIRST Award supporting a study of medium-term (six-month) stimulant treatment in adults with ADHD. This investigation will document the translation of improvement in ADHD symptoms into increased functional capacities and quality of life.

Return to Top

James M. Swanson, Ph.D.
Child Development Center
University of California, Irvine
19722 MacArthur
Irvine, CA 92612

Dr. Swanson received his doctorate from Ohio State Unviersity and is a Professor of Pediatrics and Cognitive Sciences at the University of California, Irvine. At the University of California, Irvine, Dr. Swanson founded the Child Development Center (UCI-CDC), which has speciality programs for ADHD children. The UCI-CDC school programs include a school-based day treatment program and a paraprofessional program for delivering school-based interventions for ADHD students in regular classrooms in the public schools. The UCI-CDC research program includes investigations of multimodality treatment of ADHD children, investigations of the neurobiology of ADHD, and pharmacological investigations of new medications for ADHD. Over the past 20 years, his work with ADHD children has been supported by the Ontario mental Health Foundation, the MacArthur Foundation, The Irvine Community Foundation, the Educational Foundation of America, the Sackler Foundation, the U.S. Department of Education, the National Institute of Mental Health, and the National Institute on Child Health and Development.

Return to Top

Mark L. Wolraich, M.D.
Child Development Center
Vanderbilt University
2100 Pierce Avenue, MCS Room 405
Nashville, TN 37232-3573

Dr. Wolraich is a Professor of Pediatrics and the Director of the Division of Child Development in the Department of Pediatrics at Vanderbilt University in Nashville, Tennessee. He received his medical degree from the State University of New York Upstate Medical Center in Syracuse, New York. Since his appointment at Vanderbilt, Dr. Wolraich has assumed several leadership positions to include his current directorships of the Child Development Center (since 1990) and the Junior League Center for Chronic Illnesses and Disabilities in Children. His research interests include ADHD, diet and behavior relationships, professional expectations and prognostications towards developmentally disabled children, and communication between physicians and patients or parents. Dr. Wolraich was the recipient of the Society of Pediatric Psychology’s 1999 Lee Salk Distinguished Service Award. His current research efforts include A NIMH funded research into ways pediatricians and schools can to enhance ADHD treatment effectiveness and a Maternal and Child Health Bureau funded study of rural leadership education about individuals with neurodevelopmental and related disorders and their families in Tennessee.

Return to Top

Julie M. Zito, Ph.D.
Pharmacy Practice and Science
Center for Drugs and Public Policy
101 North Greene Street, 5th Floor
Baltimore, MD 21201

Dr. Zito is an Associate Professor of Pharmacy and Medicine at the University of Maryland, Baltimore. For the past 15 years, Dr. Zito has specialized in the pharmacoepidemiology of psychiatric disorders and analyses of patterns of psychotropic medication for the treatment of mental disorders, using data from usual practice settings (psychiatric inpatients, Medicaid and HMO populations). She has over 50 publications covering such varied topics such as adult schizophrenia, [Patient Outcomes Research Team (PORT)] and psychotropic medication treatment patterns for children and adolescents. She authored a 1994 text, Psychotherapeutic Drug Manual and has authored several book chapters on applying pharmacoepidemiologic methods to the evaluation of drug therapy of adult mental disorders and child psychiatric/behavioral disorders.

Dr. Zito is an editorial board member of Medical Care and the Journal of Child and Adolescent Psychopharmacology. She is active in the American Public Health Association Medical Care section where she will be Section Chair for the next two years. She teaches a graduate course in Pharmacoepidemiology. Advocacy issues include direct-to-consumer prescription drug advertising, FDA drug evaluation, and access to health care for the poor.

 [Return to Top]